NSF
SBIR Phase II: Scaling Platforms for Translational Research and Therapeutic Screening
SBIR Phase II: Scaling Platforms for Translational Research and Therapeutic Screening is a funding opportunity from NSF, closing July 31, 2028.
Jul 31, 2028
(732d left)Overview
The broader impact /commercial potential of this Small Business Innovation Research (SBIR) Phase II project aims to establish a scalable and data-rich platform. The project has three main objectives: (1) expand the current biobank with increased metadata acquisition, (2) automate culture and imaging workflows with…